Returns to R&D on new drug introductions in the 1980s.

Returns to R&D on new drug introductions in the 1980s.

Item
http://www.wikidata.org/entity/Q33557020
Drugs for neglected diseases: a failure of the market and a public health failure?Impediments to drug development.The role of investigative molecular toxicology in early stage drug development.Cutting the cost of drug development?Strategic challenges in neurotherapeutic pharmaceutical development.The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors.Reconciling Estimates of the Value to Firms of Reduced Regulatory Delay in the Marketing of Their New Drugs.Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts.The financial performance of the health care industry: a global, regional and industry specific empirical investigation.The opportunity cost of capital: development of new pharmaceuticals.How excluding some benefits from value assessment of new drugs impacts innovation.A multi-agent simulation of the pharmaceutical supply chain
P2860

Returns to R&D on new drug introductions in the 1980s.

Item
http://www.wikidata.org/entity/Q33557020
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Returns to R&D on new drug introductions in the 1980s.
@ast
Returns to R&D on new drug introductions in the 1980s.
@en
Returns to R&D on new drug introductions in the 1980s.
@nl
type
label
Returns to R&D on new drug introductions in the 1980s.
@ast
Returns to R&D on new drug introductions in the 1980s.
@en
Returns to R&D on new drug introductions in the 1980s.
@nl
prefLabel
Returns to R&D on new drug introductions in the 1980s.
@ast
Returns to R&D on new drug introductions in the 1980s.
@en
Returns to R&D on new drug introductions in the 1980s.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Returns to R&D on new drug introductions in the 1980s.
@en
P2093
P304
P31
P356
10.1016/0167-6296(94)90010-8
P433
P478
P577
P698